Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoxetine and hemostatic function: a pilot study

M Berk1, B F Jacobson, E Hurly

  • 1Department of Psychiatry, University of the Witwatersrand, Johannesburg, South Africa.

The Journal of Clinical Psychiatry
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammation and late-life depressive symptoms.

medRxiv : the preprint server for health sciences·2026
Same author

Family History and Solar Insolation in Bipolar I Disorder.

Acta psychiatrica Scandinavica·2026
Same author

Clot twist - D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Pulmonary ultrasound in COVID-19 and non-COVID-19 pneumonia in South Africa: An observational study.

African journal of thoracic and critical care medicine·2025
Same author

Early Online.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Equal remission rates and reduced length of hospital stay with twice-daily repetitive transcranial magnetic stimulation (rTMS) for major depression - A large naturalistic retrospective cohort association study.

Progress in neuro-psychopharmacology & biological psychiatry·2023
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

This study found no significant impairment in blood clotting function in patients treated with fluoxetine. While fluoxetine is generally safe, rare bleeding events may still occur as an idiosyncratic reaction.

Area of Science:

  • Pharmacology
  • Hematology
  • Clinical Medicine

Background:

  • Case reports suggest fluoxetine may impair hemostatic function.
  • Previous literature on fluoxetine and bleeding risk is limited.

Purpose of the Study:

  • To investigate the effect of fluoxetine on hemostatic function.
  • To determine if fluoxetine therapy compromises blood clotting.

Main Methods:

  • Evaluated 10 patients with major depression before and after fluoxetine treatment.
  • Assessed a comprehensive panel of coagulation and platelet function tests.
  • Included tests like PT, PTT, fibrinogen, bleeding time, and platelet aggregation.

Main Results:

  • No statistically significant changes were observed in any measured hemostatic parameters.

Related Experiment Videos

  • Comprehensive coagulation and platelet function tests showed no impairment.

    • Conclusions:

    • Fluoxetine therapy did not demonstrate compromised hemostatic function in this study.
    • A type II statistical error is possible; rare idiosyncratic bleeding reactions cannot be ruled out.